{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:04:20Z","timestamp":1792782260090,"version":"4.5.0"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":474,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T00:00:00Z","timestamp":1719532800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Heart Initiative"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Inflammation has emerged as a potential key pathophysiological mechanism in heart failure (HF) in general and acute HF (AHF) specifically, with inflammatory biomarkers shown to be highly predictive of adverse outcomes in these patients. The CORTAHF study builds on both these data and the fact that steroid burst therapy has been shown to be effective in the treatment of respiratory diseases and COVID-19. Our hypothesis is that in patients with AHF and elevated C-reactive protein (CRP) levels without symptoms or signs of infection, a 7-day course of steroid therapy will lead to reduced inflammation and short-term improvement in quality of life and a reduced risk of worsening HF (WHF) events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>The study, which is currently ongoing, will include 100 patients with AHF ages 18\u201385, regardless of ejection fraction, screened within 12 h of presentation. Patients will be included who have NT-proBNP &amp;gt; 1500 pg\/mL and CRP &amp;gt; 20 mg\/L at screening. Exclusion criteria include haemodynamic instability and symptoms and signs of infection. After signed consent, eligible patients will be randomized according to a central randomization scheme stratified by centre 1:1 to either treatment once daily for 7 days with 40 mg prednisone orally or to standard care. Patients will be assessed at study day 2, day 4 or at discharge if earlier, and at days 7 and 31 at the hospital; and at day 91 through a telephone follow-up. The primary endpoint is the change in CRP level from baseline to day 7, estimated from a mixed model for repeated measures (MMRM) including all measured timepoints, in patients without a major protocol violation. Secondary endpoints include the time to the first event of WHF adverse event, readmission for HF, or death through day 91; and changes to day 7 in EQ-5D visual analogue scale score and utility index. Additional clinical and laboratory measures will be assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The results of the study will add to the knowledge of the role of inflammation in AHF and potentially inform the design of larger studies with possibly longer duration of anti-inflammatory therapies in AHF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.14930","type":"journal-article","created":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T00:40:20Z","timestamp":1719621620000},"page":"2672-2680","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Corticosteroid Burst Therapy in Patients with Acute Heart Failure: Design of the CORTAHF Pilot Study"],"prefix":"10.1093","volume":"11","author":[{"given":"Gad","family":"Cotter","sequence":"first","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, INSERM UMR-S 942 (MASCOT) , Paris ,","place":["France"]},{"name":"Heart Initiative , Durham, NC ,","place":["USA"]},{"name":"Momentum Research, Inc. , Durham, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Davison","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, INSERM UMR-S 942 (MASCOT) , Paris ,","place":["France"]},{"name":"Heart Initiative , Durham, NC ,","place":["USA"]},{"name":"Momentum Research, Inc. , Durham, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonathan","family":"Freund","sequence":"additional","affiliation":[{"name":"IMProving Emergency Care FHU, Sorbonne Universit\u00e9 , Paris ,","place":["France"]},{"name":"Emergency Department and Service Mobile d'Urgence et de R\u00e9animation (SMUR), H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Assistance Publique-H\u00f4pitaux de Paris (AP-HP) , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Mebazaa","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, INSERM UMR-S 942 (MASCOT) , Paris ,","place":["France"]},{"name":"Department of Anesthesiology and Critical Care and Burn Unit, Saint-Louis and Lariboisi\u00e8re Hospitals, FHU PROMICE, DMU Parabol, APHP Nord , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriaan","family":"Voors","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Medical Centre Groningen, University of Groningen , Groningen ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Edwards","sequence":"additional","affiliation":[{"name":"Momentum Research, Inc. , Durham, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Novosadova","sequence":"additional","affiliation":[{"name":"Momentum Research, Inc. , Durham, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0213-1509","authenticated-orcid":false,"given":"Koji","family":"Takagi","sequence":"additional","affiliation":[{"name":"Momentum Research, Inc. , Durham, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamlet","family":"Hayrapetyan","sequence":"additional","affiliation":[{"name":"Erebouni Medical Center , Yerevan ,","place":["Armenia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andranik","family":"Mshetsyan","sequence":"additional","affiliation":[{"name":"\u2018Mikaelyan\u2019 Surgery Institute CJSC , Yerevan ,","place":["Armenia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drambyan","family":"Mayranush","sequence":"additional","affiliation":[{"name":"\u2018Armenia\u2019 Medical Center , Yerevan ,","place":["Armenia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Cohen-Solal","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, INSERM UMR-S 942 (MASCOT) , Paris ,","place":["France"]},{"name":"Department of Cardiology, APHP Nord, Lariboisi\u00e8re University Hospital , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jozine M.","family":"ter Maaten","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Medical Centre Groningen, University of Groningen , Groningen ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Biegus","sequence":"additional","affiliation":[{"name":"Institute of Heart Diseases, Wroclaw Medical University , Wroclawa ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Ponikowski","sequence":"additional","affiliation":[{"name":"Institute of Heart Diseases, Wroclaw Medical University , Wroclawa ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerasimos","family":"Filippatos","sequence":"additional","affiliation":[{"name":"National and Kapodistrian University of Athens, School of Medicine, Attikon University Hospital , Haidari ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ovidiu","family":"Chioncel","sequence":"additional","affiliation":[{"name":"Emergency Institute for Cardiovascular Diseases \u2018Prof. C.C. Iliescu\u2019, University of Medicine \u2018Carol Davila\u2019 , Bucharest ,","place":["Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Pagnesi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, ASST Spedali Civili and Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia , Brescia ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tabassome","family":"Simon","sequence":"additional","affiliation":[{"name":"IMProving Emergency Care FHU, Sorbonne Universit\u00e9 , Paris ,","place":["France"]},{"name":"Department of Clinical Pharmacology and Clinical Research Platform Paris-East (URCEST-CRC-CRB), St Antoine Hospital, APHP , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Metra","sequence":"additional","affiliation":[{"name":"Department of Cardiology, ASST Spedali Civili and Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia , Brescia ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas L.","family":"Mann","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Cardiovascular, Center for Cardiovascular Research, Washington University School of Medicine , St. Louis, MO ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,6,28]]},"reference":[{"key":"2026012113143897900_ehf214930-bib-0001","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1056\/NEJMoa2203094","article-title":"Acetazolamide in acute decompensated heart failure with volume overload","volume":"387","author":"Mullens","year":"2022","journal-title":"N Engl J Med"},{"key":"2026012113143897900_ehf214930-bib-0002","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/ejhf.2077","article-title":"Is acute heart failure a distinctive disorder? An analysis from BIOSTAT-CHF","volume":"23","author":"Davison","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2026012113143897900_ehf214930-bib-0003","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1161\/CIRCULATIONAHA.105.535435","article-title":"Acute systemic inflammation increases arterial stiffness and decreases wave reflections in healthy individuals","volume":"112","author":"Vlachopoulos","year":"2005","journal-title":"Circulation"},{"key":"2026012113143897900_ehf214930-bib-0004","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/ejhf.1482","article-title":"The clinical significance of interleukin-6 in heart failure: Results from the BIOSTAT-CHF study","volume":"21","author":"Markousis-Mavrogenis","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2026012113143897900_ehf214930-bib-0005","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12872-023-03149-3","article-title":"Effect of C-reactive protein on the risk of heart failure: A mendelian randomization study","volume":"23","author":"Habibi","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"2026012113143897900_ehf214930-bib-0006","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.cardfail.2014.02.002","article-title":"High-sensitivity C-reactive protein in acute heart failure: Insights from the ASCEND-HF trial","volume":"20","author":"Kalogeropoulos","year":"2014","journal-title":"J Card Fail"},{"key":"2026012113143897900_ehf214930-bib-0007","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ijcard.2016.10.038","article-title":"Inflammation versus mechanical stretch biomarkers over time in acutely decompensated heart failure with reduced ejection fraction","volume":"226","author":"Boulogne","year":"2017","journal-title":"Int J Cardiol"},{"key":"2026012113143897900_ehf214930-bib-0008","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/cvr\/cvz198","article-title":"High-sensitivity C-reactive protein in chronic heart failure: Patient characteristics, phenotypes, and mode of death","volume":"116","author":"Pellicori","year":"2020","journal-title":"Cardiovasc Res"},{"key":"2026012113143897900_ehf214930-bib-0009","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1007\/s00380-019-01435-9","article-title":"Association between C-reactive protein levels at hospital admission and long-term mortality in patients with acute decompensated heart failure","volume":"34","author":"Matsumoto","year":"2019","journal-title":"Heart Vessels"},{"key":"2026012113143897900_ehf214930-bib-0010","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/biom11111701","article-title":"Differences in the biomarker profile of de novo acute heart failure versus decompensation of chronic heart failure","volume":"11","author":"Nawrocka-Millward","year":"2021","journal-title":"Biomolecules"},{"key":"2026012113143897900_ehf214930-bib-0011","doi-asserted-by":"publisher","first-page":"494","DOI":"10.2459\/JCM.0000000000000974","article-title":"Persistent congestion, renal dysfunction and inflammatory cytokines in acute heart failure: A prognosis study","volume":"21","author":"Pugliese","year":"2020","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"2026012113143897900_ehf214930-bib-0012","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/s0002-9149(03)00545-9","article-title":"Comparison of inflammatory and neurohormonal activation in cardiogenic pulmonary edema secondary to ischemic versus nonischemic causes","volume":"92","author":"Milo","year":"2003","journal-title":"American Journal of Cardiology"},{"key":"2026012113143897900_ehf214930-bib-0013","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.cardfail.2021.01.006","article-title":"Interleukin-6 and outcomes in acute heart failure: An ASCEND-HF substudy","volume":"27","author":"Perez","year":"2021","journal-title":"J Card Fail"},{"key":"2026012113143897900_ehf214930-bib-0014","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000330409","article-title":"Neurohormonal activation in acute heart failure: results from VERITAS","volume":"119","author":"Milo-Cotter","year":"2011","journal-title":"Cardiology"},{"key":"2026012113143897900_ehf214930-bib-0015","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.cardfail.2015.12.014","article-title":"Monocyte subsets and inflammatory cytokines in acute decompensated heart failure","volume":"22","author":"Goonewardena","year":"2016","journal-title":"J Card Fail"},{"key":"2026012113143897900_ehf214930-bib-0016","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.amjcard.2022.06.037","article-title":"Neutrophil-to-lymphocyte ratio and outcomes in patients admitted for acute heart failure (as seen in the BLAST-AHF, pre-RELAX-AHF, and RELAX-AHF studies)","volume":"180","author":"Davison","year":"2022","journal-title":"Am J Cardiol"},{"key":"2026012113143897900_ehf214930-bib-0017","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.amjcard.2013.08.047","article-title":"Effects of interleukin-1 blockade with anakinra on aerobic exercise capacity in patients with heart failure and preserved ejection fraction (from the D-HART pilot study)","volume":"113","author":"Van","year":"2014","journal-title":"Am J Cardiol"},{"key":"2026012113143897900_ehf214930-bib-0018","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033438","article-title":"Enhanced interleukin-1 activity contributes to exercise intolerance in patients with systolic heart failure","volume":"7","author":"Van","year":"2012","journal-title":"PLoS ONE"},{"key":"2026012113143897900_ehf214930-bib-0019","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1097\/FJC.0000000000000378","article-title":"Interleukin-1 blockade in acute decompensated heart failure: A randomized, double-blinded","volume":"67","author":"Van","year":"2016","journal-title":"Placebo-Controlled Pilot Study J Cardiovasc Pharmacol"},{"key":"2026012113143897900_ehf214930-bib-0020","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.118.005036","article-title":"IL-1 blockade in patients with heart failure with preserved ejection fraction","volume":"11","author":"Van","year":"2018","journal-title":"Circ Heart Fail"},{"key":"2026012113143897900_ehf214930-bib-0021","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.117.004373","article-title":"Interleukin-1 blockade in recently decompensated systolic heart failure: Results from REDHART (recently decompensated heart failure anakinra response trial)","volume":"10","author":"Van","year":"2017","journal-title":"Circ Heart Fail"},{"key":"2026012113143897900_ehf214930-bib-0022","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jchf.2013.11.006","article-title":"Anti-inflammatory treatment with colchicine in stable chronic heart failure: A prospective, randomized study","volume":"2","author":"Deftereos","year":"2014","journal-title":"JACC Heart Fail"},{"key":"2026012113143897900_ehf214930-bib-0023","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1093\/eurheartj\/ehab115","article-title":"Efficacy and safety of low-dose colchicine in patients with coronary disease: A systematic review and meta-analysis of randomized trials","volume":"42","author":"Fiolet","year":"2021","journal-title":"Eur Heart J"},{"key":"2026012113143897900_ehf214930-bib-0024"},{"key":"2026012113143897900_ehf214930-bib-0025","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1056\/NEJMoa2100433","article-title":"Interleukin-6 receptor antagonists in critically ill patients with Covid-19","volume":"384","author":"REMAP-CAP Investigators","year":"2021","journal-title":"N Engl J Med"},{"key":"2026012113143897900_ehf214930-bib-0026"},{"key":"2026012113143897900_ehf214930-bib-0027","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/FJC.0000000000000048","article-title":"Cardiac outcome prevention effectiveness of glucocorticoids in acute decompensated heart failure: COPE-ADHF study","volume":"63","author":"Liu","year":"2014","journal-title":"J Cardiovasc Pharmacol"},{"key":"2026012113143897900_ehf214930-bib-0028","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/s0828-282x(07)70840-1","article-title":"Potent diuretic effects of prednisone in heart failure patients with refractory diuretic resistance","volume":"23","author":"Liu","year":"2007","journal-title":"Can J Cardiol"},{"key":"2026012113143897900_ehf214930-bib-0029","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1002\/ehf2.13926","article-title":"Effect of systemic corticosteroid therapy for acute heart failure patients with elevated C-reactive protein","volume":"9","author":"Mir\u00f3","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012113143897900_ehf214930-bib-0030","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12872-018-0778-4","article-title":"Is there a C-reactive protein value beyond which one should consider infection as the cause of acute heart failure?","volume":"18","author":"Pereira","year":"2018","journal-title":"BMC Cardiovasc Disord"},{"key":"2026012113143897900_ehf214930-bib-0031","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.clinbiochem.2009.08.007","article-title":"C-reactive protein to distinguish pneumonia from acute decompensated heart failure","volume":"42","author":"Joffe","year":"2009","journal-title":"Clin Biochem"},{"key":"2026012113143897900_ehf214930-bib-0032","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)","volume":"20","author":"Herdman","year":"2011","journal-title":"Qual Life Res"},{"key":"2026012113143897900_ehf214930-bib-0033","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12874-016-0144-0","article-title":"Single time point comparisons in longitudinal randomized controlled trials: Power and bias in the presence of missing data","volume":"16","author":"Ashbeck","year":"2016","journal-title":"BMC Med Res Methodol"},{"key":"2026012113143897900_ehf214930-bib-0034","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s43441-021-00348-y","article-title":"Mixed models for repeated measures should include time-by-covariate interactions to assure power gains and robustness against dropout bias relative to complete-case ANCOVA","volume":"56","author":"Schuler","year":"2022","journal-title":"Ther Innov Regul Sci"},{"key":"2026012113143897900_ehf214930-bib-0035","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1002\/jcph.1914","article-title":"Influence of prednisone on inflammatory biomarkers in community-acquired pneumonia: Secondary analysis of a randomized trial","volume":"61","author":"Raess","year":"2021","journal-title":"J Clin Pharmacol"},{"key":"2026012113143897900_ehf214930-bib-0036","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1161\/CIRCRESAHA.116.302317","article-title":"Innate immunity and the failing heart: The cytokine hypothesis revisited","volume":"116","author":"Mann","year":"2015","journal-title":"Circ Res"},{"key":"2026012113143897900_ehf214930-bib-0037","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1161\/CIRCRESAHA.116.302317","article-title":"Immune mechanisms in heart failure","volume":"19","author":"Zhang","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026012113143897900_ehf214930-bib-0038","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","author":"RECOVERY Collaborative Group","year":"2021","journal-title":"N Engl J Med"},{"key":"2026012113143897900_ehf214930-bib-0039","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1177\/8755122521995587","article-title":"Corticosteroids in community-acquired pneumonia: A review of current literature","volume":"37","author":"Harris","year":"2021","journal-title":"J Pharm Technol"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/11\/5\/2672\/64514943\/eschf_11_5_2672.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/11\/5\/2672\/64514943\/eschf_11_5_2672.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T18:16:31Z","timestamp":1769019391000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/11\/5\/2672\/8271236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,28]]},"references-count":39,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,6,28]]},"published-print":{"date-parts":[[2024,10,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.14930","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,6,28]]},"assertion":[{"value":"2024-04-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}